Skip to Content
Merck
  • CR6-interacting factor 1 inhibits invasiveness by suppressing TGF-β-mediated epithelial-mesenchymal transition in hepatocellular carcinoma.

CR6-interacting factor 1 inhibits invasiveness by suppressing TGF-β-mediated epithelial-mesenchymal transition in hepatocellular carcinoma.

Oncotarget (2017-12-08)
Runzhou Zhuang, Di Lu, Jianyong Zhuo, Xuanyu Zhang, Kun Wang, Xuyong Wei, Qiang Wei, Wei Wang, Haiyang Xie, Lin Zhou, Xiao Xu, Shusen Zheng
ABSTRACT

CR6-interacting factor 1 (CRIF1) regulates cell cycle progression and the DNA damage response. Here, we show that CRIF1 expression is decreased in hepatocellular carcinoma (HCC) tissues and positively correlates with patients' survival.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Monoclonal Anti-β-Actin antibody produced in mouse, clone AC-15, ascites fluid